Anjarium Biosciences raised €51M in a Series A round in Sep 2021. The company is based in Schlieren, Switzerland. Investors in the round: Abingworth, Gimv, Omega Funds and 2 others. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
